In men with osteoporosis/osteopenia, denosumab, alendronate, and zoledronic acid did not differ for lumbar spine BMD at 12 mo

Lionel S. Lim, Unknown

Open source

DOI: 10.7326/annals-26-03037-jc
Published: 2026-09
Container: Annals of Internal Medicine
Publisher: American College of Physicians
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.7326/annals-26-03037-jc,
  title = {In men with osteoporosis/osteopenia, denosumab, alendronate, and zoledronic acid did not differ for lumbar spine BMD at 12 mo},
  author = {Lionel S. Lim and Unknown},
  year = {2026},
  journal = {Annals of Internal Medicine},
  doi = {10.7326/annals-26-03037-jc},
  url = {https://doi.org/10.7326/annals-26-03037-jc}
}

RIS

TY  - JOUR
TI  - In men with osteoporosis/osteopenia, denosumab, alendronate, and zoledronic acid did not differ for lumbar spine BMD at 12 mo
AU  - Lionel S. Lim
AU  - Unknown
PY  - 2026
JO  - Annals of Internal Medicine
DO  - 10.7326/annals-26-03037-jc
UR  - https://doi.org/10.7326/annals-26-03037-jc
ER  -

APA

Lim, L. S., & Unknown (2026). In men with osteoporosis/osteopenia, denosumab, alendronate, and zoledronic acid did not differ for lumbar spine BMD at 12 mo. Annals of Internal Medicine. https://doi.org/10.7326/annals-26-03037-jc

Source records

crossref · retrieved 2026-09-25T20:08:06.237Z